metabolic syndrome
Integrating Natural Language Processing and Exercise Monitoring for Early Diagnosis of Metabolic Syndrome: A Deep Learning Approach
Zhao, Yichen, Wang, Yuhua, Cheng, Xi, Fang, Junhao, Yang, Yang
Metabolic syndrome (MetS) is a medication condition characterized by abdominal obesity, insulin resistance, hypertension and hyperlipidemia. It increases the risk of majority of chronic diseases, including type 2 diabetes mellitus, and affects about one quarter of the global population. Therefore, early detection and timely intervention for MetS are crucial. Standard diagnosis for MetS components requires blood tests conducted within medical institutions. However, it is frequently underestimated, leading to unmet need for care for MetS population. This study aims to use the least physiological data and free texts about exercises related activities, which are obtained easily in daily life, to diagnosis MetS. We collected the data from 40 volunteers in a nursing home and used data augmentation to reduce the imbalance. We propose a deep learning framework for classifying MetS that integrates natural language processing (NLP) and exercise monitoring. The results showed that the best model reported a high positive result (AUROC=0.806 and REC=76.3%) through 3-fold cross-validation. Feature importance analysis revealed that text and minimum heart rate on a daily basis contribute the most in the classification of MetS. This study demonstrates the potential application of data that are easily measurable in daily life for the early diagnosis of MetS, which could contribute to reducing the cost of screening and management for MetS population.
- North America > United States > Texas > El Paso County > El Paso (0.05)
- Asia > China (0.05)
- Research Report > Experimental Study (1.00)
- Research Report > New Finding (0.68)
- Health & Medicine > Therapeutic Area > Endocrinology > Diabetes (1.00)
- Health & Medicine > Therapeutic Area > Cardiology/Vascular Diseases (1.00)
Enhancing Metabolic Syndrome Prediction with Hybrid Data Balancing and Counterfactuals
Shah, Sanyam Paresh, Mamun, Abdullah, Soumma, Shovito Barua, Ghasemzadeh, Hassan
Metabolic Syndrome (MetS) is a cluster of interrelated risk factors that significantly increases the risk of cardiovascular diseases and type 2 diabetes. Despite its global prevalence, accurate prediction of MetS remains challenging due to issues such as class imbalance, data scarcity, and methodological inconsistencies in existing studies. In this paper, we address these challenges by systematically evaluating and optimizing machine learning (ML) models for MetS prediction, leveraging advanced data balancing techniques and counterfactual analysis. Multiple ML models, including XGBoost, Random Forest, TabNet, etc., were trained and compared under various data balancing techniques such as random oversampling (ROS), SMOTE, ADASYN, and CTGAN. Additionally, we introduce MetaBoost, a novel hybrid framework that integrates SMOTE, ADASYN, and CTGAN, optimizing synthetic data generation through weighted averaging and iterative weight tuning to enhance the model's performance (achieving up to a 1.87% accuracy improvement over individual balancing techniques). A comprehensive counterfactual analysis is conducted to quantify the feature-level changes required to shift individuals from high-risk to low-risk categories. The results indicate that blood glucose (50.3%) and triglycerides (46.7%) were the most frequently modified features, highlighting their clinical significance in MetS risk reduction. Additionally, probabilistic analysis shows elevated blood glucose (85.5% likelihood) and triglycerides (74.9% posterior probability) as the strongest predictors. This study not only advances the methodological rigor of MetS prediction but also provides actionable insights for clinicians and researchers, highlighting the potential of ML in mitigating the public health burden of metabolic syndrome.
- North America > United States > Arizona > Maricopa County > Tempe (0.04)
- North America > United States > Arizona > Maricopa County > Phoenix (0.04)
- Health & Medicine > Therapeutic Area > Endocrinology > Diabetes (1.00)
- Health & Medicine > Therapeutic Area > Cardiology/Vascular Diseases (1.00)
Deep Phenotyping of Non-Alcoholic Fatty Liver Disease Patients with Genetic Factors for Insights into the Complex Disease
Priya, Tahmina Sultana, Leng, Fan, Luehrs, Anthony C., Klee, Eric W., Allen, Alina M., Lazaridis, Konstantinos N., Danfeng, null, Yao, null, Tian, Shulan
Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disorder characterized by the excessive accumulation of fat in the liver in individuals who do not consume significant amounts of alcohol, including risk factors like obesity, insulin resistance, type 2 diabetes, etc. We aim to identify subgroups of NAFLD patients based on demographic, clinical, and genetic characteristics for precision medicine. The genomic and phenotypic data (3,408 cases and 4,739 controls) for this study were gathered from participants in Mayo Clinic Tapestry Study (IRB#19-000001) and their electric health records, including their demographic, clinical, and comorbidity data, and the genotype information through whole exome sequencing performed at Helix using the Exome+$^\circledR$ Assay according to standard procedure (www$.$helix$.$com). Factors highly relevant to NAFLD were determined by the chi-square test and stepwise backward-forward regression model. Latent class analysis (LCA) was performed on NAFLD cases using significant indicator variables to identify subgroups. The optimal clustering revealed 5 latent subgroups from 2,013 NAFLD patients (mean age 60.6 years and 62.1% women), while a polygenic risk score based on 6 single-nucleotide polymorphism (SNP) variants and disease outcomes were used to analyze the subgroups. The groups are characterized by metabolic syndrome, obesity, different comorbidities, psychoneurological factors, and genetic factors. Odds ratios were utilized to compare the risk of complex diseases, such as fibrosis, cirrhosis, and hepatocellular carcinoma (HCC), as well as liver failure between the clusters. Cluster 2 has a significantly higher complex disease outcome compared to other clusters. Keywords: Fatty liver disease; Polygenic risk score; Precision medicine; Deep phenotyping; NAFLD comorbidities; Latent class analysis.
- North America > United States > Virginia (0.05)
- Asia > China (0.04)
- Europe > Slovenia > Drava > Municipality of Benedikt > Benedikt (0.04)
- Health & Medicine > Therapeutic Area > Hepatology (1.00)
- Health & Medicine > Therapeutic Area > Gastroenterology (1.00)
- Health & Medicine > Therapeutic Area > Endocrinology > Diabetes (0.88)
ChatGPT Writes Convincing Medical Study for a Fictional Wonder Drug
ChatGPT is a culmination of Reinforcement Learning optimization strategies, specifically Proximal Policy Optimization (PPO). OpenAI leveraged AI trainers to rank the model and shape rewards based on model ranking. Make no mistake: reinforcement learning requires constant iterations, trial and error, rewarding unintended behaviors, etc. The computational barrier to entry is costly in compute costs and time to train. However, it is one of the most effective conversational AI's to date.
- Research Report > Experimental Study (1.00)
- Research Report > New Finding (0.82)
- Research Report > New Finding (1.00)
- Research Report > Experimental Study (0.80)
- Health & Medicine > Therapeutic Area > Cardiology/Vascular Diseases (1.00)
- Health & Medicine > Therapeutic Area > Endocrinology > Diabetes (0.31)
- Information Technology > Artificial Intelligence > Machine Learning > Neural Networks (1.00)
- Information Technology > Artificial Intelligence > Machine Learning > Statistical Learning > Regression (0.44)
- Information Technology > Artificial Intelligence > Machine Learning > Statistical Learning > Support Vector Machines (0.30)